BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20589319)

  • 21. Heterozygous Bβ-chain C-terminal 12 amino acid elongation variant, BβX462W (Kyoto VI), showed dysfibrinogenemia.
    Okumura N; Terasawa F; Takezawa Y; Hirota-Kawadobora M; Inaba T; Fujita N; Saito M; Sugano M; Honda T
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):87-90. PubMed ID: 22001526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A functional assay suggests that heterodimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV.
    Hogan KA; Lord ST; Okumura N; Terasawa F; Galanakis DK; Scharrer I; Gorkun OV
    Thromb Haemost; 2000 Apr; 83(4):592-7. PubMed ID: 10780323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
    Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
    Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia.
    Homer VM; Brennan SO; Ockelford P; George PM
    Thromb Haemost; 2002 Sep; 88(3):427-31. PubMed ID: 12353071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation.
    Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
    Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
    Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
    Brennan SO; Davis RL
    Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression.
    Brennan SO; Oliver J; Davis RL
    Thromb Haemost; 2011 Feb; 105(2):379-81. PubMed ID: 21057694
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala-->Gly and an intron two GT-->AT splice site mutation.
    Wyatt J; Brennan SO; May S; George PM
    Thromb Haemost; 2000 Sep; 84(3):449-52. PubMed ID: 11019970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
    Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
    Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala -->Val substitution (fibrinogen Dorfen).
    Dear A; Brennan SO; Dempfle CE; Kirschstein W; George PM
    Thromb Haemost; 2004 Dec; 92(6):1291-5. PubMed ID: 15583736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assembly and secretion of mutant fibrinogens with variant gamma-chain C terminal region (gamma313-gamma345)].
    Terasawa F; Kamijyo Y; Fujihara N; Okumura N
    Rinsho Byori; 2010 Aug; 58(8):772-8. PubMed ID: 20860169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
    Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
    de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
    Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream.
    Robert-Ebadi H; de Moerloose P; El Khorassani M; El Khattab M; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):385-7. PubMed ID: 19417632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
    Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
    Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypofibrinogenemia associated with a heterozygous missense mutation gamma153Cys to arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen.
    Terasawa F; Okumura N; Kitano K; Hayashida N; Shimosaka M; Okazaki M; Lord ST
    Blood; 1999 Dec; 94(12):4122-31. PubMed ID: 10590057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
    Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
    Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.